Founded by the people who kept seeing it missed.

GuideAI Health was established by clinicians to close a gap they encountered in practice: early peripheral arterial disease sitting unread in imaging acquired for another reason.

Origin

A pattern, then a model.

Dr. Raj Shah and Dr. Luke Higgins — both interventional radiologists — kept encountering the same thing: patients arriving with advanced peripheral arterial disease whose earlier imaging, taken for something else entirely, had already contained the signs.

They began developing computer-vision models to detect vascular markers in that existing imaging. Dr. Amin Katouzian joined to scale the AI infrastructure and carry the work through regulatory readiness.

The mission has not changed since: enable earlier intervention, before disease becomes irreversible. That means detecting PAD markers before symptoms appear, reducing adverse cardiovascular events, and delivering insight that is actionable without disrupting the radiology workflow it arrives in.

Milestones

Four years, clinical genesis to clearance.

— 2022–2023Clinical genesis Founded by practising interventional radiologists. First computer-vision models developed for vascular marker detection in existing imaging. Founding

— 2024Into the clinic Clinical pilots launched. Named a Company to Watch at the LSI Emerging Medtech Summit. Pilots

— 2025Recognition and availability Featured in Canada’s Drug Agency Horizon Scan. Commercial availability begins. Commercial

— 2026Clearance and listing FDA 510(k) clearance for VascularAssist Occlusion Triage, with up to 95% patient-level sensitivity reported in validation. Listed on Cboe Canada (GDAI) and the Frankfurt Stock Exchange (ZN0). Cleared

Leadership